1. ACS Omega. 2022 Oct 14;7(42):37873-37884. doi: 10.1021/acsomega.2c04980. 
eCollection 2022 Oct 25.

Evaluating Allosteric Perturbations in Cannabinoid Receptor 1 by In Silico 
Single-Point Mutation.

Díaz O(1)(2)(3), Renault P(1)(2)(3), Giraldo J(1)(2)(3).

Author information:
(1)Laboratory of Molecular Neuropharmacology and Bioinformatics, Unitat de 
Bioestadística and Institut de Neurociències, Universitat Autònoma de Barcelona, 
Bellaterra 08193, Spain.
(2)Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de 
Salud Mental (CIBERSAM), Madrid 28029, Spain.
(3)Unitat de Neurociència Traslacional, Parc Taulí Hospital Universitari, 
Institut d'Investigació i Innovació Parc Taulí (I3PT), Institut de 
Neurociències, Universitat Autònoma de Barcelona, Bellaterra 08193, Spain.

Cannabinoid receptor 1 (CB1) is a promising drug target involved in many 
physiological processes. Using atomistic molecular dynamics (MD) simulations, we 
examined the structural effect of F237L mutation on CB1, a mutation that has 
qualitatively similar effects to allosteric ligand ORG27569 binding. This 
mutation showed a global effect on CB1 conformations. Among the observed 
effects, TM6 outward movement and the conformational change of the NPxxY motif 
upon receptor activation by CB1 agonist CP55940 were hindered compared to wt 
CB1. Within the orthosteric binding site, CP55940 interactions with CB1 were 
altered. Our results revealed that allosteric perturbations introduced by the 
mutation had a global impact on receptor conformations, suggesting that the 
mutation site is a key region for allosteric modulation in CB1.

© 2022 The Authors. Published by American Chemical Society.

DOI: 10.1021/acsomega.2c04980
PMCID: PMC9608382
PMID: 36312415

Conflict of interest statement: The authors declare no competing financial 
interest.